Neupro and Hepatic function abnormal - a phase IV clinical study of FDA data

Summary:

Hepatic function abnormal is reported as a side effect among people who take Neupro (rotigotine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Comtan, and have Constipation.

The phase IV clinical study analyzes which people have Hepatic function abnormal when taking Neupro. It is created by eHealthMe based on reports of 11,313 people who have side effects when taking Neupro from the FDA, and is updated regularly.

What is Neupro?

Neupro has active ingredients of rotigotine. It is often used in parkinson's disease. eHealthMe is studying from 11,393 Neupro users. Check the latest studies of Neupro.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,446 drugs and 2,016 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.

On Apr, 29, 2026

11,313 people reported to have side effects when taking Neupro.
Among them, 25 people (0.22%) have Hepatic function abnormal.

Could Neupro cause Hepatic function abnormal?

Among these 25 people:

How long have people been on Neupro when they have Hepatic function abnormal? *

What is the gender of people who have Hepatic function abnormal when taking Neupro? *

female: 50 %
male: 50 %

What is the age of people who have Hepatic function abnormal when taking Neupro? *

What are other drugs people take besides Neupro? *

What are other side effects people have besides Hepatic function abnormal? *

Pneumonia: 5 people, 20.00%
Hoarseness Or Changing Voice: 4 people, 16.00%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 3 people, 12.00%
Cardiac Failure Congestive: 3 people, 12.00%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 3 people, 12.00%
Hyperkalemia (damage to or disease of the kidney): 3 people, 12.00%
Cardiomyopathy (weakening of the heart muscle): 2 people, 8.00%
Blood Pressure Fluctuation: 2 people, 8.00%
Itching: 2 people, 8.00%
Oxygen Saturation Decreased: 2 people, 8.00%

What are the existing conditions these people have? *

Constipation: 4 people, 16.00%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 4.00%
Pain: 1 person, 4.00%
Osteoporosis (bones weak and more likely to break): 1 person, 4.00%
Nausea (feeling of having an urge to vomit): 1 person, 4.00%
Multiple System Atrophy (degeneration of nerve cells in specific areas of the brain): 1 person, 4.00%
High Blood Pressure: 1 person, 4.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.00%
Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 4.00%
Enlarged Prostate: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Neupro and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neupro:

Neupro (11,393 reports)

Browse all side effects of Neupro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic function abnormal:

Hepatic function abnormal (1,446 drugs)

Browse all the conditions that are associated with Hepatic function abnormal:

Hepatic function abnormal (2,016 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rotigotine (the active ingredients of Neupro) and Neupro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.